Notably, FB23 exhibited almost 140-fold stronger activity than meclofenamic acid (MA) in inhibiting FTO enzymatic activity in acute myeloid leukemia (AML) 9, 13. The gene discussed is FTO; the disease is acute myeloid leukemia.